AB
NAVB
Amalgamated Bank’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-794
| Closed | -$15K | – | 1412 |
|
|
2016
Q1 | $15K | Buy |
794
+69
| +10% | +$1.3K | ﹤0.01% | 1284 |
|
|
2015
Q4 | $19K | Sell |
725
-60
| -8% | -$1.57K | ﹤0.01% | 1195 |
|
|
2015
Q3 | $36K | Buy |
785
+6
| +0.8% | +$275 | ﹤0.01% | 1275 |
|
|
2015
Q2 | $25K | Buy |
779
+157
| +25% | +$5.04K | ﹤0.01% | 1358 |
|
|
2015
Q1 | $20K | Buy |
622
+29
| +5% | +$932 | ﹤0.01% | 932 |
|
|
2014
Q4 | $22K | Buy |
593
+1
| +0.2% | +$37 | ﹤0.01% | 852 |
|
|
2014
Q3 | $16K | Buy |
592
+3
| +0.5% | +$81 | ﹤0.01% | 840 |
|
|
2014
Q2 | $17K | Buy |
589
+51
| +9% | +$1.47K | ﹤0.01% | 869 |
|
|
2014
Q1 | $20K | Sell |
538
-2
| -0.4% | -$74 | ﹤0.01% | 832 |
|
|
2013
Q4 | $22K | Buy |
+540
| New | +$22K | ﹤0.01% | 836 |
|